Vitrolife AB Stock Nasdaq Stockholm
Equities
SE0000816043
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.6B 330M | Sales 2025 * | 3.98B 365M | Capitalization | 22.11B 2.03B |
---|---|---|---|---|---|
Net income 2024 * | 530M 48.63M | Net income 2025 * | 677M 62.12M | EV / Sales 2024 * | 6.31 x |
Net Debt 2024 * | 600M 55.06M | Net cash position 2025 * | 103M 9.48M | EV / Sales 2025 * | 5.53 x |
P/E ratio 2024 * |
41.7
x | P/E ratio 2025 * |
32.7
x | Employees | - |
Yield 2024 * |
0.83% | Yield 2025 * |
0.85% | Free-Float | 55.39% |
Latest transcript on Vitrolife AB
Managers | Title | Age | Since |
---|---|---|---|
Bronwyn Brophy
CEO | Chief Executive Officer | - | 23-07-31 |
Patrik Tolf
DFI | Director of Finance/CFO | 54 | 21-12-31 |
Chairman | 68 | 15-05-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 19-05-01 | |
Chairman | 68 | 15-05-06 | |
Director/Board Member | 64 | 18-04-26 |
1st Jan change | Capi. | |
---|---|---|
+0.89% | 12.8B | |
-10.29% | 7.61B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.3B | |
+12.21% | 2.73B | |
-11.50% | 1.73B | |
-5.02% | 1.64B | |
-8.80% | 1.53B |